CW · Curtiss-Wright Corporation — research history

Curtiss-Wright is a high-quality aerospace & defense / nuclear industrial conglomerate with strong Q1 2026 results and raised FY26 guidance. The trigger was a cluster of Form 4 filings — but upon reading all transactions, the signal is entirely composed of pre-arranged SELLING under 10b5-1 plans (CEO Bamford $3.8M in sales; no open-market buys from insiders). Options flow shows a large ITM call block at $750 strike on Aug expiry (363 contracts, V/OI=6.6) with net directional bias bullish at +91% — consistent with covered-call writing rather than new directional conviction. The stock is near its 52-week high ($800 vs $771.93 close), richly valued at forward P/E 45x and EV/EBITDA 35.6x, and has run ~40% YTD. No compelling mispricing edge exists given the valuation premium, and insider activity is uniformly negative.

Extreme valuation premium (44x forward P/E) combined with material insider selling and a detected bearish options block leaves zero margin of safety. The dossier confirms no undisclosed edge, and the stock trades near all-time highs without a catalyst to justify a long or income setup.

Curtiss-Wright is a high-quality defense/nuclear components manufacturer that has compounded earnings at ~20% annually, yet its valuation (44x forward P/E, 35x EV/EBITDA) leaves no margin of safety for error. The investigation trigger — '4 Form 4 filings in last 14 days · 2 real trades' — turned out to be entirely pre-planned Rule 10b5-1 sales by the CEO ($1.8M), CFO/Corp Controller, and a growth officer, plus director fee stock grants. Zero open-market insider purchases were found. The actual smart-money signal is insiders selling near all-time highs. A single large bearish put structure (400 contracts at $730 strike on July 17) was detected in UOA data. The company raised full-year guidance post-Q1 beat and expanded its revolver to $1B, which could support M&A or share repurchases — but this also signals a management preference for financial flexibility rather than a conviction call on the stock. No material filing-driven edge exists; all disclosed information is already in consensus.

Curtiss-Wright is a high-quality aerospace & defense industrial with strong Q1 2026 results (EPS $3.48 vs est $3.30, +5.3% beat), raised full-year guidance, and 13% revenue growth driven by broad-based strength across all three segments (Naval & Power up 21%, Aerospace & Industrial up 12%, Defense Electronics up 5%). The stock is near its 52-week high ($760) at $733 with a forward P/E of ~43x — fully valued. Critically, the Form 4 cluster investigation revealed that the three recent filings (May 27 – June 2) are director equity compensation grants (restricted stock awards under the company's 2024 Omnibus Incentive Plan), NOT open-market purchases by executives or directors. This is a false-positive trigger: there has been no insider buying signal from the CEO, CFO, or any officer in an open-market transaction this year. The valuation is rich (EV/EBITDA ~34x) with low IV on liquid options chain, leaving no compelling asymmetric long-side setup and insufficient premium for structured income strategies at current levels.

Trading at a demanding 44x forward P/E near all-time highs with only 5.4% analyst upside, this dossier fails the >20% return threshold. Insiders are net sellers, options flow shows no high-conviction UOA, and Scout's 'range_bound_or_income' verdict confirms no asymmetric long edge exists.

Curtiss-Wright is a high-quality aerospace & defense industrial with three segments (Aerospace & Industrial, Defense Electronics, Naval & Power) generating ~$3.6B in revenue and consistently beating earnings estimates. The company recently raised 2026 guidance after a strong Q1 beat (+5.3% EPS surprise), announced an 8% dividend increase (10th consecutive year), expanded its credit facility to $1B, and moved into prototype manufacturing for X-energy's Xe-100 small modular reactor. However, the stock is at all-time highs ($747 vs. 52w high of $760.72), trading at a demanding forward P/E of ~44x and EV/EBITDA of ~34.5x — rich relative to its mid-teens earnings growth rate. No insider open-market purchases were detected in 90 days; recent Form 4s reflect director restricted stock grants (Jeffrey Lyash, Glenda Minor) and one Rule 10b5-1 scheduled sale (EVP John Watts). Options flow is mildly bullish but no whale blocks or high-conviction UOA signals. The Q1 beat was partially muted by an adjusted EBITDA shortfall relative to consensus expectations.

Curtiss-Wright reported strong Q1 2026 results (EPS $3.48 vs $3.30 estimate, +5.3%; revenue $913.7M up 13.4% YoY) and raised full-year guidance. The May 19-20 8-K revealed a routine refinancing — replacement of a $750M revolving credit facility with a new $1B syndicated facility maturing 2031. This is not an equity event; it extends debt maturity and adds accordion capacity for future M&A/growth. No CEO/CFO open-market purchases in the past 90 days. The only insider 'buy' was Director Glenda Minor receiving deferred-compensation restricted stock (not cash buying). Forward P/E of ~43x and EV/EBITDA of ~34x are substantially above defense-sector medians, sitting at or near all-time highs. Options IV is moderate (~40-50%) with thin volume. No material mispricing exists — the market has correctly repriced this company for strong defense spending exposure and nuclear power growth.

Score falls well below the 50-point threshold. The dossier explicitly notes no material edge or mispricing exists, with valuation already at a significant premium (42x Fwd P/E) and insider selling outweighing buying. Without a catalyst <30d or clear mispricing, this does not meet the publication bar.

Curtiss-Wright delivered a strong Q1 2026 beat (+5.3% EPS surprise) on May 6 and raised full-year guidance across all metrics, driven by broad-based revenue growth (+13%) in defense electronics, naval propulsion, and commercial nuclear. The stock is near its all-time high ($751 intraday on May 13) with a stretched forward P/E of ~42x and EV/EBITDA of ~33x — well above Defense sector norms. Smart-money signals are absent: zero open-market insider purchases in the past 90 days; all Form 4 activity consists of routine director equity grants. Options flow is modestly bullish but lacks whale-scale positioning. The primary bull case rests on premium-sector defense names and a nascent nuclear SMR program (X-energy Xe-100 prototype milestone). Given rich valuation + near ATH price with no mispricing, this is best classified as range_bound_or_income — not a compelling asymmetric long.

Trading at a steep premium to peers (43x Fwd P/E) at a 52-week high with zero insider conviction; the bullish options flow reflects a known catalyst already priced in rather than an unpriced edge. The dossier flags dilution and liquidity concerns, and no asymmetric or income structure offers a favorable risk/reward here.

Curtiss-Wright is a high-quality defense contractor with strong Q1 2026 results (EPS $3.46 vs $3.30 est, revenue +13% YoY to $914M) and raised full-year guidance across all metrics. The stock has had an exceptional run (+51% YTD, near 52w high at $729). The options flow shows a real bullish signal — whale OTM call blocks on Jun-18 expiry with V/OI ratios of 2.88x (650 strike) and 4.84x (720 strike), and 64% net dollar call bias. However, no open-market insider purchases were found in the trailing period: recent Form 4s are exclusively RSU vest+sell transactions by mid-level executives (CFO Farkas, COO Rayment, Treasurer Freda) — not conviction buys. The X-energy Xe-100 SMR prototype manufacturing announcement is a genuine long-duration catalyst but already widely covered. CW trades at 43x forward P/E and 33x EV/EBITDA versus a sector median closer to 20-22x EV/EBITDA for mid-tier defense names, leaving essentially no mispricing margin.